Details van artikel 199 van 292 gevonden artikelen
Phase 2 Study of Pomalidomide (POM) + Low-Dose Dexamethasone (LoDEX) Following Second-Line Lenalidomide (LEN)-Based Treatment (Tx) in Patients (Pts) With Relapsed or Refractory Multiple Myeloma (RRMM): An Updated Analysis of Efficacy and Safety
Titel:
Phase 2 Study of Pomalidomide (POM) + Low-Dose Dexamethasone (LoDEX) Following Second-Line Lenalidomide (LEN)-Based Treatment (Tx) in Patients (Pts) With Relapsed or Refractory Multiple Myeloma (RRMM): An Updated Analysis of Efficacy and Safety
Auteur:
Siegel, David S. Schiller, Gary J. Song, Kevin Agajanian, Richy Stockerl-Goldstein, Keith Kaya, Hakan Sebag, Michael Reu, Frederic J. Malek, Eshan Mouro, Jorge Chung, Weiyuan Srinivasan, Shankar Qian, Max Rizvi, Syed Thakurta, Anjan Bahlis, Nizar J.
Verschenen in:
Clinical lymphoma myeloma and leukemia
Paginering:
Jaargang 17 (2017) nr. 1S pagina's 1 p.
Jaar:
2017
Inhoud:
Uitgever:
Published by Elsevier B.V.
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 199 van 292 gevonden artikelen